Women's Perspectives on Contraceptive-Induced Amenorrhea in Burkina Faso and Uganda

CONTEXT: Women's concerns about contraceptive-induced menstrual changes can lead to method discontinuation and nonuse, contributing to unmet need for contraception. Research on women's perceptions of amenorrhea related to longer acting methods and in low-income countries is limited. METHODS: Data were from nationally representative household surveys and focus group discussions with women of reproductive age conducted in Burkina Faso and Uganda in 2016-2017. Bivariate cross-tabulations and multivariate logistic regression analyses were used to examine sociodemographic and reproductive characteristics associated with women's attitudes about contraceptive-induced amenorrhea (n=2,673 for Burkina Faso and 2,281 for Uganda); menstrual health determinants were also examined for Burkina Faso. Qualitative data from focus group discussions were analyzed to understand reasons behind women's attitudes and how they influence contraceptive decision making. RESULTS: Sixty-five percent of women in Burkina Faso and 40% in Uganda reported they would choose a method that caused amenorrhea during use. In Burkina Faso, the predicted probability of accepting amenorrhea was higher for women aged 15-19 (compared with older women), living in rural areas, married and cohabiting (compared with never married), currently using a contraceptive method (compared with never users) and from Mossi households (compared with Gourmantché); menstrual health practices were not associated with amenorrhea acceptability. In Uganda, the least wealthy women had the highest predicted probability of accepting amenorrhea (51%). Qualitative analysis revealed a variety of reasons for women's attitudes about amenorrhea and differences by country, but the relationship between these attitudes and contraceptive decision making was similar across countries. CONCLUSIONS: Addressing misconceptions about contraception and menstruation may result in more informed method decision making

Towards Unification for Pointing Task Evaluation in 3D Desktop Virtual Environment

International audienceNew visualization systems for large and complex datasets are emerging and 3D Virtual Environments turn out to be a relevant solution. Interaction tasks in these 3D VE have been defined, especially to support evaluation of these applications. Nevertheless there is a lack of unified protocol to assess these elementary tasks in this context. Moreover it can be complex to determine the appropriate technique to perform these tasks as there is a lack of reference data. A standard is available for 2D pointing task, but there is no equivalence in 3D. In this paper, we propose an adaptation of this standard to a pointing task in a 3D VE. We detail our protocol and an instrumentation, which aims at assessing performance, comfort of techniques and satisfaction of users. We also present results of a user experimentation conducted according to this standard’s adaptation

Impacts of Porous Pavements on Soil Environment and Street Tree Growth

This presentation will showcase the complete results of a two-year experimental study into the relative effects of porous and impervious pavement on urban soils and trees. The study contrasts a factorial combination of pavement types and profile designs in order to comprehensively understand the effects of porous pavement in urban environments. The objective was to determine whether porous pavements would prove beneficial to planted trees in hardscape settings. Key results to be presented include the effect of pavement type and design on root abundance, diameter, and biomass, as well as stem height, diameter, and biomass. The response of these tree growth factors will be linked with the measured impact of pavements on soil moisture, aeration, pH, and nutrient availability. Though some of these results have previously been presented and published, this presentation will, for the first time, combine all aspects of the study and, in doing so, challenge the perceived benefits of porous paving

Domain wall generation by fermion self-interaction and light particles

A possible explanation for the appearance of light fermions and Higgs bosons on the four-dimensional domain wall is proposed. The mechanism of light particle trapping is accounted for by a strong self-interaction of five-dimensional pre-quarks. We obtain the low-energy effective action which exhibits the invariance under the so called \tau-symmetry. Then we find a set of vacuum solutions which break that symmetry and the five-dimensional translational invariance. One type of those vacuum solutions gives rise to the domain wall formation with consequent trapping of light massive fermions and Higgs-like bosons as well as massless sterile scalars, the so-called branons. The induced relations between low-energy couplings for Yukawa and scalar field interactions allow to make certain predictions for light particle masses and couplings themselves, which might provide a signature of the higher dimensional origin of particle physics at future experiments. The manifest translational symmetry breaking, eventually due to some gravitational and/or matter fields in five dimensions, is effectively realized with the help of background scalar defects. As a result the branons acquire masses, whereas the ratio of Higgs and fermion (presumably top-quark) masses can be reduced towards the values compatible with the present-day phenomenology. Since the branons do not couple to fermions and the Higgs bosons do not decay into branons, the latter ones are essentially sterile and stable, what makes them the natural candidates for the dark matter in the Universe.Comment: 34 pages, 2 figures, JHEP style,few important refs. adde

Bridging Digital and Physical Worlds Using Tangible Drag-and-Drop Interfaces

The last ten years have seen an explosion in the diversity of digital-life devices, e.g. music and video players. However, the interaction paradigm to use these devices has remained mostly unchanged. Remote controls are still the most common way to manage a digital-life device. Moreover, the interaction between devices themselves is still very limited and rarely addressed by a remote control interface. We present in this paper a study of tangible drag-and-drop, a remote control interface based on the well-known paradigm coming from the graphical user interface. This interaction technique aims at reducing the gap between the digital and physical worlds, enabling the transfer of digital data from one device to another. To validate such a concept, we present two prototypes, along with user studies and a general discussion about the tangible drag-and-drop technique

Catalysis of Dynamical Flavor Symmetry Breaking by a Magnetic Field in 2+12+1 Dimensions

It is shown that in $2+1$ dimensions, a constant magnetic field is a strong catalyst of dynamical flavor symmetry breaking, leading to generating a fermion dynamical mass even at the weakest attractive interaction between fermions. The effect is illustrated in the Nambu-Jona-Lasinio model in a magnetic field. The low-energy effective action in this model is derived and the thermodynamic properties of the model are established. The relevance of this effect for planar condensed matter systems is pointed out.Comment: 11 pages, LaTeX. The final version (with minor corrections) which appeared in Phys.Rev.Lett. 73 (1994) 349

Global maps of soil temperature.

Research in global change ecology relies heavily on global climatic grids derived from estimates of air temperature in open areas at around 2 m above the ground. These climatic grids do not reflect conditions below vegetation canopies and near the ground surface, where critical ecosystem functions occur and most terrestrial species reside. Here, we provide global maps of soil temperature and bioclimatic variables at a 1-km <sup>2</sup> resolution for 0-5 and 5-15 cm soil depth. These maps were created by calculating the difference (i.e. offset) between in situ soil temperature measurements, based on time series from over 1200 1-km <sup>2</sup> pixels (summarized from 8519 unique temperature sensors) across all the world's major terrestrial biomes, and coarse-grained air temperature estimates from ERA5-Land (an atmospheric reanalysis by the European Centre for Medium-Range Weather Forecasts). We show that mean annual soil temperature differs markedly from the corresponding gridded air temperature, by up to 10°C (mean = 3.0 ± 2.1°C), with substantial variation across biomes and seasons. Over the year, soils in cold and/or dry biomes are substantially warmer (+3.6 ± 2.3°C) than gridded air temperature, whereas soils in warm and humid environments are on average slightly cooler (-0.7 ± 2.3°C). The observed substantial and biome-specific offsets emphasize that the projected impacts of climate and climate change on near-surface biodiversity and ecosystem functioning are inaccurately assessed when air rather than soil temperature is used, especially in cold environments. The global soil-related bioclimatic variables provided here are an important step forward for any application in ecology and related disciplines. Nevertheless, we highlight the need to fill remaining geographic gaps by collecting more in situ measurements of microclimate conditions to further enhance the spatiotemporal resolution of global soil temperature products for ecological applications

Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial

Background: Febuxostat and allopurinol are urate-lowering therapies used to treat patients with gout. Following concerns about the cardiovascular safety of febuxostat, the European Medicines Agency recommended a post-licensing study assessing the cardiovascular safety of febuxostat compared with allopurinol. Methods: We did a prospective, randomised, open-label, blinded-endpoint, non-inferiority trial of febuxostat versus allopurinol in patients with gout in the UK, Denmark, and Sweden. Eligible patients were 60 years or older, already receiving allopurinol, and had at least one additional cardiovascular risk factor. Those who had myocardial infarction or stroke in the previous 6 months or who had severe congestive heart failure or severe renal impairment were excluded. After a lead-in phase in which allopurinol dose was optimised towards achieving a serum urate concentration of less than 0·357 mmol/L (<6 mg/dL), patients were randomly assigned (1:1, with stratification according to previous cardiovascular events) to continue allopurinol (at the optimised dose) or start febuxostat at 80 mg/day, increasing to 120 mg/day if necessary to achieve the target serum urate concentration. The primary outcome was a composite of hospitalisation for non-fatal myocardial infarction or biomarker-positive acute coronary syndrome; non-fatal stroke; or cardiovascular death. The hazard ratio (HR) for febuxostat versus allopurinol in a Cox proportional hazards model (adjusted for the stratification variable and country) was assessed for non-inferiority (HR limit 1·3) in an on-treatment analysis. This study is registered with the EU Clinical Trials Register (EudraCT 2011-001883-23) and ISRCTN (ISRCTN72443728) and is now closed. Findings: From Dec 20, 2011, to Jan 26, 2018, 6128 patients (mean age 71·0 years [SD 6·4], 5225 [85·3%] men, 903 [14·7%] women, 2046 [33·4%] with previous cardiovascular disease) were enrolled and randomly allocated to receive allopurinol (n=3065) or febuxostat (n=3063). By the study end date (Dec 31, 2019), 189 (6·2%) patients in the febuxostat group and 169 (5·5%) in the allopurinol group withdrew from all follow-up. Median follow-up time was 1467 days (IQR 1029–2052) and median on-treatment follow-up was 1324 days (IQR 870–1919). For incidence of the primary endpoint, on-treatment, febuxostat (172 patients [1·72 events per 100 patient-years]) was non-inferior to allopurinol (241 patients [2·05 events per 100 patient-years]; adjusted HR 0·85 [95% CI 0·70–1·03], p<0·0001). In the febuxostat group, 222 (7·2%) of 3063 patients died and 1720 (57·3%) of 3001 in the safety analysis set had at least one serious adverse event (with 23 events in 19 [0·6%] patients related to treatment). In the allopurinol group, 263 (8·6%) of 3065 patients died and 1812 (59·4%) of 3050 had one or more serious adverse events (with five events in five [0·2%] patients related to treatment). Randomised therapy was discontinued in 973 (32·4%) patients in the febuxostat group and 503 (16·5%) patients in the allopurinol group. Interpretation: Febuxostat is non-inferior to allopurinol therapy with respect to the primary cardiovascular endpoint, and its long-term use is not associated with an increased risk of death or serious adverse events compared with allopurinol. Funding: Menarini, Ipsen, and Teijin Pharma Ltd